RESISTANCE MECHANISMS

Resistance to ivermectin has become a significant problem in many parts of the world, a problem that continues to grow with increase use of anthelmintics in animals and humans. Resistance to ivermectin may be conferred by the expression of P-glycoproteins. P-gp as it is commonly known is a membrane protein that has the ability to transport aromatic, hydrophobic drugs from cell membranes and cytoplasms. These proteins are considered to cause drug resistance in mammalian tumor cells and various parasites such as Plasmodium falciparum (Figure 1).

Figure 1. A schematic of how a P-glycoprotein would work within a cell.

In ivermectin resistance, the P-glycoproteins may work by binding to and transporting ivermectin out of cells. Studies of Haemonchus contortus (a type of sheep nematode) support this hypothesis. In the wild, many populations of H. contortus have been found to be resistant. One study found that treatment with ivermectin in H. contortus resulted in higher levels of P-glycoprotein mRNA compared to unselected strains. P-glycoprotein gene structure was also altered in the treatment group.(Xu, Molento et al. 1998)
Another method of conferring resistance may involve changes in the structure of the glutamate-gated chloride channel themselves. At least one study has found that treatment with Ivermectin results in selection pressures on the gene for the alpha-subunit of the glutamate channel in H. contortus. (Blackhall, Pouliot et al. 1998)

Figure 2. Resistance in Haemonchus contortus, a sheep nematode, is widespread.


Of particular concern to humans is the development of resistance in Onchocerca vovulus, the parasite that causes River Blindess. . One study found the possibility of selection for P-glycoprotein homologs and Beta-tubulin occurred in patients infected with O. volvulus and treated with Ivermectin and another study found small populations of treated individuals that do not clear infection completely. (Eng and Prichard 2005) Thus far, there has been no solid documented evidence of resistance to Ivermectin, but the potential for its development remains.

Figure 3. Resistance has not been documented in Onchocerca vovulus, but it may be a question of when not if this will occur.

 

Back to top


Pictures provided by: http://www.biotechjournal.com/Journal/Mar2002/marArticle1text.htm, http://nema.cap.ed.ac.uk/nematodeESTs/nem.html
http://news.bbc.co.uk/1/hi/health/779698.stm